Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial

There is no fulltext present in this item.

Title:	Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial
Author(s):	Lamers-Karnebeek, F.B.G.; Luime, J.J.; Jansen, T.L; Riel, P. van ; Jacobs, J.W.G.
Publication year:	2020
Source:	Rheumatology, vol. 59, iss. 5, (2020), pp. 1170-1171
ISSN:	1462-0324
DOI:	https://doi.org/10.1093/rheumatology/kez488
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/225880
Display more details
Subject:	Radboudumc 18: Healthcare improvement science RIHS: Radboud Institute for Health Sciences Tijdelijke code tbv inlezen publicaties Radboudumc - Alleen voor gebruik door Radboudumc
Organization:	Rheumatology IQ Healthcare
Journal title:	Rheumatology
Volume:	vol. 59
Issue:	iss. 5
Page start:	p. 1170
Page end:	p. 1171